Answers are grounded in this paper and cite their sources.
The MUC4 mucin is a transmembrane glycoprotein that is implicated in the pathogenesis of pancreatic cancer and is aberrantly expressed in many other epithelial carcinomas. Recent studies suggest its significant potential as a clinical tool for cancer diagnosis and prognosis. MUC4 modulates HER2/ErbB2 signaling and is a determinant of therapeutic outcome of Herceptin-based therapy, which further indicates its prospective usefulness in cancer therapy and treatment planning.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: